VKTX
Viking Therapeutics, Inc. Earnings
$41.05
Earnings Summary
Revenue | $0Mn |
Net Profits | $-24.94Mn |
Net Profit Margins | -Inf% |
Viking Therapeutics, Inc.’s revenue jumped NaN% since last year same period to $0Mn in the Q3 2024. On a quarterly growth basis, Viking Therapeutics, Inc. has generated NaN% jump in its revenue since last 3-months.
Viking Therapeutics, Inc.’s net profit fell -10.68% since last year same period to $-24.94Mn in the Q3 2024. On a quarterly growth basis, Viking Therapeutics, Inc. has generated -12.09% fall in its net profits since last 3-months.
Viking Therapeutics, Inc.’s net profit margin jumped NaN% since last year same period to -Inf% in the Q3 2024. On a quarterly growth basis, Viking Therapeutics, Inc. has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Viking Therapeutics, Inc. post its latest quarter earningsEPS Estimate Current Quarter | -0.28 |
EPS Estimate Current Year | -0.28 |
Viking Therapeutics, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.28 - a -12% fall from last quarter’s estimates.
Viking Therapeutics, Inc.’s earning per share (EPS) estimates for the current year stand at -0.28.
Key Ratios
Key ratios of the Viking Therapeutics, Inc. post its Q3 2024 earningsEarning Per Share (EPS) | -0.22 |
Viking Therapeutics, Inc.’s earning per share (EPS) jumped 4.35% since last year same period to -0.22 in the Q3 2024. This indicates that the Viking Therapeutics, Inc. has generated 4.35% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-07-24 | -0.27 | -0.2 | 25.93% |
2024-04-25 | -0.28 | -0.26 | 7.14% |
2024-10-23 | -0.25 | -0.22 | 12% |
₹0 US Stocks a/c Opening Fee